Acute amphotericin B overdose

Annals of Pharmacotherapy

Volumn 40, Issue 12, 2006, Pages 2254-2259

  Burke, Douglas ^a   Lal, Rajiv ^a   Finkel, Kevin W ^a   Samuels, Joshua ^a   Foringer, John R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Amphotericin B; Toxicity

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; HEPARIN; TIROFIBAN;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; BRADYCARDIA; CARDIOTOXICITY; CASE REPORT; CRYPTOCOCCAL MENINGITIS; DISEASE COURSE; DRUG OVERDOSE; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPOTENSION; INTENSIVE CARE UNIT; MEDICATION ERROR; METABOLIC ACIDOSIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA;

ACUTE DISEASE; ADULT; AMPHOTERICIN B; ARRHYTHMIA; CHEMISTRY, PHARMACEUTICAL; DEOXYCHOLIC ACID; DRUG COMBINATIONS; FATAL OUTCOME; FEMALE; HUMANS; MEDICATION ERRORS; MENINGITIS, CRYPTOCOCCAL; OVERDOSE;

EID: 33845643676     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H157     Document Type: Article

References (24)

1. Hoeprich P. Clinical use of amphotericin B and derivatives: lore, mystique, and fact. Clin Infect Dis 1992;14(suppl):S114-9.
2. Ruckwardt T, Scott A, Scott J, Mikulecky P, Hartsel S. Lipid and stress dependence of amphotericin B ion selective channels in sterol-free membranes. Biochim Biophys Acta 1998;1372:283-8.
3. Soler J, Iban L, Zuazu J, Julia A. Bradycardia after rapid infusion of amphotericin B. Lancet 1993;341:372-3.
4. Cleary JD, Hayman J, Sherwood J, Lasala GP, Piazza-Hepp T. Amphotericin B overdose in pediatric patients with associated cardiac arrest. Ann Pharmacother 1993;27:715-9.
5. Thakur CP. Sodium antimony gluconate, amphotericin, and myocardial damage. Lancet 1998;351:1928-9.
6. Aguado J, Hidalgo M, Moya I, Alcazar J, Jimenez M, Noriega A. Ventricular arrhythmias and conventional and liposomal amphotericin (letter). Lancet 1993;342:1239.
7. DeMonaco HB, McGovern B. Transient asystole associated with amphotericin B infusion. Drug Intell Clin Pharm 1983;17:547-8.
8. Chung D, Koenig M. Reversible cardiac enlargement during treatment with amphotericin B and hydrocortisone. Am Rev Respir Dis 1971;103: 831-41.
9. Ruiz-Ceretti E, Schanne F, Bonnardeaux J. Effects of amphotericin B on isolated rabbit hearts. J Mol Cell Cardiol 1976;8:77-88.
10. Schanne O, Ruiz-Ceretti E, Deslauriers Y, Payet D, Soulier P, Demers S. The effects of amphotericin B on the ionic currents of frog atrial trabeculae. J Mol Cell Cardiol 1977;9:909-20.
11. Butler W, Bennett J, Hill G, Szwed C, Cotlove E. Electrocardiographic and electrolyte abnormalities caused by amphotericin B in dog and man. Proc Soc Exp Biol Med 1964;116:857-63.
12. Laska D, Williams P, White S, Thompson C, Hoover D. In vitro correlation of ultrastructural morphology and creatine phosphokinase release in L6 skeletal muscle cells after exposure to parenteral antibiotics. In Vitro Cell Dev Biol 1990;26:393-8.
13. Levine S, Walsh T, Martinez A, Eichacker P, Lopez-Berenstein G, Natanson C. Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann Intern Med 1991;114:664-6.
14. Heard H, Richert J, Taylor R. The treatment of deep mycotic infections with amphotericin B: with particular emphasis on drug toxicity. Am Rev Respir Dis 1960;81:43-51.
15. Lin A, Goldwasser E, Bernard E, Chapman S. Amphotericin B blunts erythropoietin response to anemia. J Infect Dis 1990;161:348-51.
16. Keim G, Poutsiaka J, Kirpan J, Keysser C. Amphotericin B methyl ester hydrochloride and amphotericin B: comparative acute toxicity. Science 1979;179:584-5.
17. Heyman S, Stillman E, Brezis M, Epstein F, Spokes K, Rosen S. Chronic amphotericin nephropathy: morphometric, electron microscopic, and functional studies. J Am Soc Nephrol 1993;4:69-80.
18. Halpern S, Lindeman R. Effect of amphotericin B on the renal clearance of urea in man. Proc Soc Exp Biol Med 1970;134:1073-7.
19. Cheng J, Witty R, Robinson R, Yarger W. Amphotericin B nephrotoxicity: increased renal resistance and increased tubule permeability. Kidney Int 1982;22:626-33.
20. Suschek C, Bonmann E, Kleinert H, et al. Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability. Br J Pharmacol 2000;131: 473-81.
21. Reiner N, Thompson W. Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs. J Infect Dis 1979;140:564-75.
22. Brooks D, Mitchell M, Short B, Ruffolo R, Nichols A. Attenuation of amphotericin B nephrotoxicity in the dog by the fenoldopam prodrug, SK&F R-105058. J Pharmacol Exp Ther 1991;3:1243-7.
23. Gussak H, Rahman S, Bastani B. Administration and clearance of amphotericin B during high-efficiency or high-efficiency/high-flux dialysis. Am J Kidney Dis 2001;37:E45.
24. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.